Valirx (VAL)

 

Latest News

Re: SHARES Magazine Supplement on ValiRx website

RNS Number: 5389D ValiRx PLC 27 April 2017 VALIRX PLC ("ValiRx", "the Company") Re: The SHARES Magazine Supplement " ValiRx And The Drug Development Journey", is now available on the ValiRx website London, UK., 27 April 2017: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company , is pleased to report that a recent supplement on the ...

Change of Registered Office

RNS Number: 6512C ValiRx PLC 19 April 2017 Va li R x P lc ("ValiRx" or "the Company") Change of Registered Office London, UK ., 18 April 2017: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, announces that it has changed its registered office to 16 Upper Woburn Place, London, WC1H 0BS. This announcement is inside information for the purpo...

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, bought 400,000 shares in the company on the 15th March 2017 at a price of 2.50p. T...

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, bought 400,000 shares in the company on the 15th March 2017 at a price of 2.50p. T...

All News

DateHeadlineSource
27-04-17Re: SHARES Magazine Supplement on ValiRx websiteRNS
19-04-17Change of Registered OfficeRNS
15-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
15-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
15-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
15-03-17Director/PDMR ShareholdingRNS
08-03-17ValiSeek Clinical Development UpdateRNS
08-03-17ValiRX - Projects updateBRR Media
02-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
02-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
02-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
02-03-17Director/PDMR ShareholdingRNS
01-03-17ValiRx raises £1.16m via placingStockMarketWire
01-03-17Placing to raise ?1.16m and Proposed SubscriptionRNS
28-02-17Publication of Peer-Reviewed Articles on VAL401RNS
11-01-17ValiRx notes positive VAL201 clinical trialStockMarketWire
11-01-17CLINICAL TRIAL UPDATE - Positive VAL201 ResultsRNS
30-12-16ValiRx notes Yorkville CLN conversionStockMarketWire
30-12-16Yorkville CLN ConversionRNS
08-12-16ValiRx says European patent granted for VAL201StockMarketWire
08-12-16European Patent Granted for Lead Compound VAL201RNS
02-12-16ValiRx loan draw downStockMarketWire
02-12-16Convertible Loan FacilityRNS
01-12-16ValiRx notes ValiSeek clinical development updateStockMarketWire
01-12-16ValiSeek Clinical Development UpdateRNS
01-12-16ValiRx Plc - ValiSeek Clinical Development UpdateBRR Media
29-11-16Quarterly Update on Clinical DevelopmentsRNS
03-11-16ValiSeek Clinical Development UpdateRNS
02-11-16ValiRx plc - Valiseek clinical development update BRR Media
28-10-16Corporate Video re Clinical Status Q4, 2016RNS
28-10-16ValiRX - Clinical Status Q4 2016BRR Media
25-10-16ValiRx issues patent updateStockMarketWire
25-10-16Patent UpdateRNS
13-10-16Holding(s) in CompanyRNS
13-10-16Holding(s) in CompanyRNS
13-10-16Update on Recent PresentationsRNS
12-10-16Result of General MeetingRNS
05-10-16CLN ConversionRNS
28-09-16Notice of GMRNS
27-09-16Half-year ReportRNS

RSS feeds

  • Editorial news feed for LSE:VAL Editorial
  • Regulatory news feed for LSE:VAL Regulatory